UniProt ID | Protein Name | Gene Symbol ▲ | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A6P3IT53 | Angiotensin-converting enzyme |
|
6 | 0 |
|
A0A6P3GTP4 | Angiotensin-converting enzyme |
|
2 | 0 |
|
A0A6P3GIK4 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
A0A6P3H3Y4 | A disintegrin and metalloproteinase with thrombospondin motifs 1 |
|
2 | 0 |
|
A0A6P3HCA7 | LOW QUALITY PROTEIN: A disintegrin and metalloproteinase with thrombospondin motifs 5 |
|
2 | 0 |
|
A0A6P3HS62 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6P3I570 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6P3ICK5 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A6P3H407 | Beta-secretase 2 |
|
2 | 0 |
|
A0A6P3IHC7 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6P3HY94 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6P3I5S8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6P3IGG9 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A6P3HLN3 | Cathepsin D |
|
2 | 0 |
|
A0A6P3IT90 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6P3J1M0 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6P3IYU1 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6P3J2I6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6P3ITF9 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A6P3G5B2 | Protein adenylyltransferase FICD |
|
1 | 0 |
|
A0A6P3HUL1 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A6P3HFR2 | Hemopexin |
|
1 | 0 |
|
A0A6P3I671 | Hyaluronidase |
|
1 | 0 |
|
A0A6P3IGV1 | Hyaluronidase |
|
1 | 0 |
|
A0A6P3IGU6 | Hyaluronidase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024